For the Inventor, By the Inventor

Enter assignee name

Glenmark Pharmaceuticals Limited

USPTO Granted Patents = 31

EPO Patents = 9

Trademarks = 1

Forward Citations = 88

Loading Chart...

Loading Chart...

113 inventors (with patents filed for the assignee):

Shekhar Bhaskar Bhirud (19 out of 28 patents)

Samir Naik (7 out of 10 patents)

Sachin Srivastava (5 out of 5 patents)

4. Ulhas R Dhuppad (4 out of 22 patents)

5. Kumar Hari Bhushan (4 out of 6 patents)

6. Sushanta Mishra (4 out of 5 patents)

7. Sukumar Sinha (3 out of 8 patents)

8. Suresh Babu Narayanan (3 out of 3 patents)

9. Bobba Venkata Siva Kumar (3 out of 4 patents)

10. Batchu Chandrasekhar (3 out of 3 patents)

11. Ashok Katkurwar (2 out of 11 patents)

12. Dilipkumar Jibhau Patil (2 out of 2 patents)

13. Abhijit Pardeshi (2 out of 2 patents)

14. Sachin Bhagwan Naykodi (2 out of 2 patents)

15. Sunil Kumar Singh (2 out of 3 patents)

31 patents: Sort by Forward Citations

1. 12502489 - Metered dose inhaler for ipratropium bromide solution (2025-12-23),

2. D914095 - Label (2021-03-23),

3. 10357622 - Dry powder inhaler (2019-07-23),

4. 10138206 - Amorphous form of lomitapide mesylate (2018-11-27),

5. 10138190 - Process for preparation of ospemifene (2018-11-27),

6. 10125115 - Process for the preparation of efinaconazole (2018-11-13),

7. 10106483 - Process for preparation of azelaic acid (2018-10-23),

8. 9840456 - Process for preparation of dimethyl fumarate (2017-12-12),

9. D804015 - Inhaler (2017-11-28),

10. 9776985 - Process for preparation of alogliptin (2017-10-03),

11. D797920 - Inhaler (2017-09-19),

12. 9695159 - Process for preparation of canagliflozin (2017-07-04),

13. 9670160 - Process for the preparation of tofacitinib and intermediates thereof (2017-06-06),

14. 9663505 - Process for the preparation of rivaroxaban (2017-05-30),

15. 9593119 - Process for the preparation of dipeptidylpeptidase inhibitors (2017-03-14),

Glenmark Pharmaceuticals Limited is a global pharmaceutical company that focuses on developing, manufacturing, and marketing innovative and affordable solutions to address critical healthcare needs. With a presence in over 80 countries, Glenmark is committed to improving the quality of life for patients by delivering high-quality and cost-effective medicines. The company specializes in areas such as dermatology, respiratory, oncology, and generics, striving to make a positive impact on healthcare globally.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

31 Patents

#11 in Mumbai

#61 in India

#20,624 in the World

Glenmark Pharmaceuticals Limited

Forward Citations = 88

113 inventors:

Shekhar Bhaskar Bhirud (19 out of 28 patents)

Samir Naik (7 out of 10 patents)

Sachin Srivastava (5 out of 5 patents)

4. Ulhas R Dhuppad (4 out of 22 patents)

5. Kumar Hari Bhushan (4 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…